参考文献/References:
[1] Shields BM,McDonald TJ,Ellard S,et al.The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes[J].Diabetologia,2012,55(5):1265-1272.DOI:10.1007/s00125-011-2418-8.Epub 2012 Jan 5.
[2] Ellard S,Colclough K.Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha(HNF1A)and 4 alpha(HNF4A)in maturity-onset diabetes of the young[J].Hum Mutat,2006,27(9):8548-8569.DOI:10.1002/humu.20357.
[3] Yamagata K,Oda N,Kaisaki PJ,et al.Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young(MODY3)[J].Nature,1996,384(6608):455-458.DOI:10.1038/384455a0.
[4] Bellanné-Chantelot C,Carette C,Riveline JP,et al.The type and the position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young(MODY)-3[J].Diabetes,2008,57(2):503-508.DOI:10.2337/db07-0859.
[5] Yabe SG,Nishida J,Fukuda S,et al.Expression of mutant mRNA and protein in pancreatic cells derived from MODY3- iPS cells[J].PLoS One,2019,14(5):e217110.DOI:10.1371/journal.pone.0217110.
[6] Dukes ID,Sreenan S,Roe MW,et al.Defective pancreatic beta-cell glycolytic signaling in hepatocyte nuclear factor-1alpha-deficient mice[J].J Biol Chem,1998,273(38):24457-24464.DOI:10.1074/jbc.273.38.24457.
[7] Pontoglio M,Sreenan S,Roe M,et al.Defective insulin secretion in hepatocyte nuclear factor 1 alpha-deficient mice[J].J Clin Invest,1998,101(10):2215-2222.DOI:10.1172/JCI2548.
[8] Colclough K,Bellanne-Chantelot C,Saint-Martin C,et al.Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia[J].Hum Mutat,2013,34(5):669-685.DOI:10.1002/humu.22279.
[9] Wang X,Wang T,Yu M,et al.Screening of HNF1A and HNF4A mutation and clinical phenotype analysis in a large cohort of Chinese patients with maturity-onset diabetes of the young[J].Acta Diabetol,2019,56(3):281-288.DOI:10.1007/s00592-018-1232-x.
[10] Bellanné-Chantelot C,Lévy DJ,Carette C,et al.Clinical characteristics and diagnostic criteria of maturity-onset diabetes of the young(MODY)due to Molecular anomalies of the HNF1A gene[J].J Clin Endocrinol Metab,2011,96(8):E1346-E1351.DOI:10.1210/jc.2011-0268.
[11] 钮恩静,董冰子,刘方超,等.酮症起病青少年发病的成年型糖尿病基因检测分析[J].精准医学杂志,2019,34(5):412-415.DOI:10.13362/j.jpmed.201905009.
[12] Pruhova S,Dusatkova P,Neumann D,et al.Two cases of diabetic ketoacidosis in HNF1A-MODY linked to severe dehydration:is it time to change the diagnostic criteria for MODY?[J].Diabetes Care,2013,36(9):2573-2574.DOI:10.2337/dc13-0058.
[13] Hattersley AT,Greeley SAW,Polak M,et al.ISPAD clinical practice consensus guidelines 2018:the diagnosis and management of monogenic diabetes in children and adolescents[J].Pediatr Diabetes,2018,19Suppl 27:47-63.DOI:10.1111/pedi.12772.
[14] Salzano G,Passanisi S,Mammì C,et al.Maturity onset diabetes of the young is not necessarily associated with autosomal inheritance:case description of a de novo HNF1A mutation[J].Diabetes Ther,2019,10(4):1543-1548.DOI:10.1007/s13300-019-0633-3.
[15] 肖建中.特殊类型糖尿病非典型表现的认识[J].中华糖尿病杂志,2018,10(9):584-586.DOI:10.3760/cma.j.issn.1674-5809.2018.09.003.
[16] 周姣姣,李鸿.MODY研究新进展[J].国际内分泌代谢杂志,2013,33(4):250-254.DOI:10.3760/cma.j.issn.1673-4157.2013.04.010.
[17] Brunerova L,Rahelic' D,Ceriello A,et al.Use of oral antidiabetic drugs in the treatment of maturity-onset diabetes of the young:a mini review[J].Diabetes Metab Res Rev,2018,34(1):1-6.DOI:10.1002/dmrr.2940.
[18] SIGMA Type 2 Diabetes Consortium; Estrada K,Aukrust I,Bjørkhaug L,et al.Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population[J].JAMA,2014,311(22):2305-2314.DOI:10.1001/jama.2014.6511.
[19] Demol S,Lebenthal Y,Bar-Meisels M,et al.A family with a novel termination mutation in hepatic nuclear factor 1a in maturity-onset diabetes of the young type 3 which is unresponsive to sulphonylurea therapy[J].Horm Res Paediatr,2014,81(4):280-284.DOI:10.1159/000356925.
[20] Tan C,Ang SF,Lim SC.Response to multiple glucose-lowering agents in a sib-pair with a novel HNF1a(MODY3)variant[J].Eur J Hum Genet,2020,28(4):518-520.DOI:10.1038/s41431-019-0561-8.